October 28, 2025 16:05 ET | Source: Tactile Systems Technology, Inc. MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems…
CHONGQING, China, Oct. 22, 2025 /PRNewswire/ -- On October 22, 2025, at the Chongqing SERES Shuangfu Plant, DFSK's first overseas new…
October 20, 2025 02:30 ET | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…
October 19, 2025 08:00 ET | Source: Replimune, Inc. WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…
Large‑platform hexagonal hub (Hextra Tech) offers superior stability and ease of grip; ISO 13485 & CE certified; launched by a leading…
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal phase…
Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïve or resistant to anti-PD-163% (26/41)…
New data demonstrate amivantamab combination significantly reduces common EGFR and MET resistance mutations seen with EGFR TKIs1 BEERSE, BELGIUM ,…
KOLKATA, India, Aug. 29, 2025 /PRNewswire/ -- Himadri Speciality Chemical Ltd (HSCL), a global leader in speciality chemicals and advanced…
August 15, 2025 07:30 ET | Source: Plus Therapeutics Inc. HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.…